Skip to main content
Top
Published in: International Urology and Nephrology 9/2018

01-09-2018 | Urology - Original Paper

Metabolic profile and impact of diet in patients with primary hyperoxaluria

Authors: Roswitha Siener, Bernd Hoppe, Patricia Löhr, Stefan C. Müller, Stefan Latz

Published in: International Urology and Nephrology | Issue 9/2018

Login to get access

Abstract

Purpose

The primary goal of this pilot study was to evaluate metabolic characteristics and to examine the impact of diet in patients with primary hyperoxaluria (PH) under controlled, standardized conditions.

Methods

Four patients with genetically confirmed PH collected 24 h urines on their habitual, self-selected diets and on day 1, 6, 7, 8, and 11 under controlled, standardized conditions. The [13C2]oxalate absorption, calcium, and ammonium chloride loading tests were performed.

Results

While none of the patients had abnormal findings from the calcium loading test, incomplete distal renal tubular acidosis (RTA) was diagnosed in each of the four patients. Dietary intervention resulted in a significant decrease in urinary oxalate expressed as molar creatinine ratio (mmol/mol) between 30 and 40% in two of four patients. The evaluation of dietary records revealed a high daily intake of oxalate-rich foods as well as gelatin-containing sweets and meat products, rich sources of hydroxyproline, under the habitual, self-selected diets of the two responders. Intestinal oxalate hyperabsorption of 12.4% in one of the two patients may have additionally contributed to the increased urinary oxalate excretion under the individual diet.

Conclusions

Our pilot data indicate that patients with PH may benefit from a restriction of dietary oxalate and hydroxyproline intake. Further research is needed to define the role of distal RTA in PH and to evaluate the hypothesis of an acquired acidification defect.
Literature
2.
3.
go back to reference Hesse A, Tiselius HG, Siener R, Hoppe B (2009) Urinary stones. Diagnosis, treatment, and prevention of recurrence, 3rd revised and enlarged edn. Karger, BaselCrossRef Hesse A, Tiselius HG, Siener R, Hoppe B (2009) Urinary stones. Diagnosis, treatment, and prevention of recurrence, 3rd revised and enlarged edn. Karger, BaselCrossRef
4.
go back to reference Leumann E, Hoppe B, Neuhaus T, Blau N (1995) Efficacy of oral citrate administration in primary hyperoxaluria. Nephrol Dial Transplant 10(Suppl 8):14–16CrossRefPubMed Leumann E, Hoppe B, Neuhaus T, Blau N (1995) Efficacy of oral citrate administration in primary hyperoxaluria. Nephrol Dial Transplant 10(Suppl 8):14–16CrossRefPubMed
5.
go back to reference Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschênes G, Unwin R, Milliner D (2011) Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant 26:3609–3615CrossRefPubMed Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschênes G, Unwin R, Milliner D (2011) Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant 26:3609–3615CrossRefPubMed
6.
go back to reference Hoyer-Kuhn H, Kohbrok S, Volland R, Franklin J, Hero B, Beck BB, Hoppe B (2014) Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice. Clin J Am Soc Nephrol 9:468–477CrossRefPubMedPubMedCentral Hoyer-Kuhn H, Kohbrok S, Volland R, Franklin J, Hero B, Beck BB, Hoppe B (2014) Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice. Clin J Am Soc Nephrol 9:468–477CrossRefPubMedPubMedCentral
7.
go back to reference Sikora P, von Unruh GE, Beck B, Feldkötter M, Zajaczkowska M, Hesse A, Hoppe B (2008) [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria. Kidney Int 73:1181–1186CrossRefPubMed Sikora P, von Unruh GE, Beck B, Feldkötter M, Zajaczkowska M, Hesse A, Hoppe B (2008) [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria. Kidney Int 73:1181–1186CrossRefPubMed
8.
go back to reference Siener R, Jahnen A, Hesse A (2004) Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr 58:270–276CrossRefPubMed Siener R, Jahnen A, Hesse A (2004) Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr 58:270–276CrossRefPubMed
9.
go back to reference von Unruh GE, Voss S, Sauerbruch T, Hesse A (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test. J Urol 169:687–690CrossRef von Unruh GE, Voss S, Sauerbruch T, Hesse A (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test. J Urol 169:687–690CrossRef
10.
go back to reference Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral
11.
go back to reference Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, van Lente F (2007) Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53:766–772CrossRefPubMed Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, van Lente F (2007) Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53:766–772CrossRefPubMed
12.
go back to reference Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC, The Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29:715–734CrossRefPubMedPubMedCentral Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC, The Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29:715–734CrossRefPubMedPubMedCentral
13.
go back to reference Pak CYC, Poindexter JR, Peterson RD, Heller HJ (2004) Biochemical and physicochemical presentations of patients with brushite stones. J Urol 171:1046–1049CrossRefPubMed Pak CYC, Poindexter JR, Peterson RD, Heller HJ (2004) Biochemical and physicochemical presentations of patients with brushite stones. J Urol 171:1046–1049CrossRefPubMed
14.
go back to reference Thamilselvan S, Khan SR (1998) Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 11:66–69PubMed Thamilselvan S, Khan SR (1998) Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 11:66–69PubMed
15.
go back to reference Parks JH, Coe FL, Evan AP, Worcester EM (2009) Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant 24:130–136CrossRefPubMed Parks JH, Coe FL, Evan AP, Worcester EM (2009) Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant 24:130–136CrossRefPubMed
16.
go back to reference Backman U, Danielson BG, Johansson G, Ljunghall S, Wikström B (1980) Incidence and clinical importance of renal tubular defects in recurrent renal stone formers. Nephron 25:96–101CrossRefPubMed Backman U, Danielson BG, Johansson G, Ljunghall S, Wikström B (1980) Incidence and clinical importance of renal tubular defects in recurrent renal stone formers. Nephron 25:96–101CrossRefPubMed
17.
go back to reference Leumann E, Hoppe B (2001) The primary hyperoxalurias. J Am Soc Nephrol 12:1986–1993PubMed Leumann E, Hoppe B (2001) The primary hyperoxalurias. J Am Soc Nephrol 12:1986–1993PubMed
18.
go back to reference Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270–276CrossRefPubMed Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270–276CrossRefPubMed
19.
go back to reference Hönow R, Hesse A (2002) Comparison of extraction methods for the determination of soluble and total oxalate in foods by HPLC-enzyme-reactor. Food Chem 78:511–521CrossRef Hönow R, Hesse A (2002) Comparison of extraction methods for the determination of soluble and total oxalate in foods by HPLC-enzyme-reactor. Food Chem 78:511–521CrossRef
20.
go back to reference Siener R, Hönow R, Seidler A, Voss S, Hesse A (2006) Oxalate contents of species of the Polygonaceae, Amaranthaceae and Chenopodiaceae families. Food Chem 98:220–224CrossRef Siener R, Hönow R, Seidler A, Voss S, Hesse A (2006) Oxalate contents of species of the Polygonaceae, Amaranthaceae and Chenopodiaceae families. Food Chem 98:220–224CrossRef
21.
go back to reference Schroder T, Vanhanen L, Savage GP (2011) Oxalate content in commercially produced cocoa and dark chocolate. J Food Compos Anal 24:916–922CrossRef Schroder T, Vanhanen L, Savage GP (2011) Oxalate content in commercially produced cocoa and dark chocolate. J Food Compos Anal 24:916–922CrossRef
22.
go back to reference Hönow R, Gu KLR, Hesse A, Siener R (2010) Oxalate content of green tea of different origin, quality, preparation and time of harvest. Urol Res 38:377–381CrossRefPubMed Hönow R, Gu KLR, Hesse A, Siener R (2010) Oxalate content of green tea of different origin, quality, preparation and time of harvest. Urol Res 38:377–381CrossRefPubMed
23.
go back to reference Siener R, Seidler A, Voss S, Hesse A (2016) The oxalate content of fruit and vegetable juices, nectars and drinks. J Food Compos Anal 45:108–112CrossRef Siener R, Seidler A, Voss S, Hesse A (2016) The oxalate content of fruit and vegetable juices, nectars and drinks. J Food Compos Anal 45:108–112CrossRef
25.
go back to reference Knight J, Holmes RP, Cramer SD, Takayama T, Salido E (2012) Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol Renal Physiol 302:F688–F693CrossRefPubMed Knight J, Holmes RP, Cramer SD, Takayama T, Salido E (2012) Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol Renal Physiol 302:F688–F693CrossRefPubMed
26.
27.
go back to reference von Unruh GE, Voss S, Sauerbruch T, Hesse A (2004) Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol 15:1567–1573CrossRef von Unruh GE, Voss S, Sauerbruch T, Hesse A (2004) Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol 15:1567–1573CrossRef
Metadata
Title
Metabolic profile and impact of diet in patients with primary hyperoxaluria
Authors
Roswitha Siener
Bernd Hoppe
Patricia Löhr
Stefan C. Müller
Stefan Latz
Publication date
01-09-2018
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 9/2018
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-1939-1

Other articles of this Issue 9/2018

International Urology and Nephrology 9/2018 Go to the issue